Amy L. Sherborne
Institute of Cancer Research(GB)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas(2012)998 cited
- → Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk(2010)259 cited
- → Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients(2017)233 cited
- → The Genetic Basis of Inbreeding Avoidance in House Mice(2007)179 cited
- → Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer(2016)167 cited
- → Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype(2013)164 cited
- → Genetic Diagnosis of High-Penetrance Susceptibility for Colorectal Cancer (CRC) Is Achievable for a High Proportion of Familial CRC by Exome Sequencing(2015)111 cited
- → Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma(2023)104 cited
- → Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients(2019)79 cited
- → Baculum morphology predicts reproductive success of male house mice under sexual selection(2013)78 cited